EDAP TMS S.A. (EDAP)'s Ablatherm-HIFU Demonstrates Long Term Efficacy, Durability and Reproducibility With Prospective Fourteen -Year Study
5/20/2013 9:37:39 AM
More...
|
EDAP TMS S.A. (EDAP) Reports 23% Increase in First Quarter 2013 Revenues
5/16/2013 9:23:04 AM
More...
|
EDAP TMS S.A. (EDAP) Schedules Webcast and Conference Call for First Quarter 2013 Results
5/14/2013 9:57:02 AM
More...
|
EDAP TMS S.A. (EDAP)'s Ablatherm-HIFU Receives Two Best Poster Awards at 2013 American Urological Association Annual Meeting
5/14/2013 9:21:16 AM
More...
|
EDAP TMS S.A. (EDAP) Ablatherm-HIFU Demonstrates Long-Term Efficacy and Safety Over Fourteen-Year Period
2/8/2013 10:35:22 AM
More...
|
EDAP TMS S.A. (EDAP) Submits U.S. FDA Pre-Market Approval Application for Ablatherm®-HIFU for Treatment of Low Risk, Localized Prostate Cancer
2/1/2013 9:01:04 AM
More...
|
EDAP TMS S.A. (EDAP) Reports 25% Year-Over-Year Revenue Growth for Fourth Quarter 2012
1/22/2013 9:11:33 AM
More...
|
EDAP TMS S.A. (EDAP) Schedules Webcast and Conference Call for Third Quarter 2012 Results
11/7/2012 9:17:24 AM
More...
|
EDAP TMS S.A. (EDAP) Highlights HIFU Expertise at Third International Symposium on Focused Ultrasound in Washington, D.C.
10/25/2012 9:26:36 AM
More...
|
EDAP TMS S.A. (EDAP) Appoints Experienced Lithotripsy Expert to Increase U.S. Sales
10/9/2012 9:20:59 AM
More...
|
|